EMA News

A top European agency has warned of a new Covid-19 wave in many countries in Europe The new wave is driven by Omicron subvariants, it said The new wave is driven by BA.4 and BA.5 which are highly-transmissible

After more than a month of decline, Covid-19 cases started to increase around the world last week, the WHO said, with lockdowns in Asia and China`s Jilin province battling to contain an outbreak.

India`s Alkem Laboratories has been accused by Germany`s health regulator of fudging data on clinical trials of an antibiotic and brain disorder drug, becoming the third Indian firm to be scrutinised since 2014 for suspected manipulation of trial data

The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.

The Swiss surveillance authority for medicines Friday checked for any corresponding preparations of the 700 generic medicines subjected to clinical trials by India's GVK Biosciences, whose marketing rights were suspended by the European Medicines Agency (EMA).

The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.